Bell Investment Advisors, Inc Verona Pharma PLC Transaction History
Bell Investment Advisors, Inc
- $533 Million
- Q4 2024
A detailed history of Bell Investment Advisors, Inc transactions in Verona Pharma PLC stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 13 shares of VRNA stock, worth $894. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 22
40.91%
Holding current value
$894
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VRNA
# of Institutions
228Shares Held
68.2MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$440 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$384 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$233 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$216 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$215 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.2B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...